chartexchange

DRUG SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Bright Minds Biosciences

PR Newswire | Nov 3, 2026 2:53 PM EST

Investors who lost money when DRUG shares sold off on the FDA's partial clinical hold for the planned Phase 2 BMB-101 epilepsy trial may have the right to seek recovery, even if they have already sold. NEW YORK, Nov. 3, 2026 /PRNewswire/ -- Shareholders of Bright Minds Biosciences...

Read original article